. Angelini, Advances and perspectives in muscular dystrophies

V. Davisson, R. Straub, D. Barresi, R. F. Bansal, R. Hrstka et al., Disruption of the sarcoglycan?sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy, Cell, vol.98, pp.465-474, 1999.

R. H. Crosbie, J. Heighway, D. P. Venzke, J. C. Lee, and K. P. Campbell, Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex, Journal of Biological Chemistry, vol.272, issue.50, pp.272-31221, 1997.
DOI : 10.1074/jbc.272.50.31221

V. Straub and K. P. Campbell, Muscular dystrophies and the dystrophin???glycoprotein complex, Current Opinion in Neurology, vol.10, issue.2, pp.168-175, 1997.
DOI : 10.1097/00019052-199704000-00016

F. Sciandra, M. Bozzi, M. Bianchi, E. Pavoni, B. Giardina et al., Dystroglycan and muscular dystrophies related to the dystrophin?glycoprotein complex, Ann. Ist. Super. Sanita, vol.39, pp.173-181, 2003.

A. A. Hack, M. E. Groh, and E. M. Mcnally, Sarcoglycans in muscular dystrophy, Sarcoglycans in muscular dystrophy, pp.167-180, 2000.
DOI : 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T

A. J. Ettinger, G. Feng, and J. R. Sanes, Epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy, J. Biol. Chem, pp.272-32534, 1997.

E. M. Mcnally, C. T. Ly, and L. M. Kunkel, Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene, FEBS Lett, pp.422-449, 1998.

. Campbell, Sarcoglycan replaces a-sarcoglycan in smooth muscle to form a unique dystrophin?glycoprotein complex, J. Biol. Chem, vol.274, pp.27989-27996, 1999.

P. Scheidtmann, J. Kern, B. Winkelmann, and . Muller-myhsok, Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome, Nat. Genet, pp.29-66, 2001.

M. T. Wheeler, S. Zarnegar, and E. M. Mcnally, zeta-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy, Human Molecular Genetics, vol.11, issue.18, pp.11-2147, 2002.
DOI : 10.1093/hmg/11.18.2147

O. Rinaldi, P. Giacobbe, G. Bramanti, A. Navarra, A. Amato et al., Sarcoglycan subcomplex in normal human smooth muscle: an immunohistochemical and molecular study, Int. J. Mol. Med, pp.16-367, 2005.

Y. M. Chan, C. G. Bonnemann, H. G. Lidov, and L. M. Kunkel, Molecular Organization of Sarcoglycan Complex in Mouse Myotubes in Culture, The Journal of Cell Biology, vol.403, issue.7, pp.2033-2044, 1998.
DOI : 10.1074/jbc.273.3.1583

H. Ueda, K. Ueda, T. Baba, and S. , Ohno, d-and c-Sarcoglycan localization in the sarcoplasmic reticulum of skeletal muscle, J. Histochem. Cytochem, pp.49-529, 2001.

. Puca, Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein, Hum. Mol. Genet, vol.5, pp.1179-1186, 1996.

K. P. Mcpherson and . Campbell, Characterization of d-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy, J. Biol. Chem, pp.271-32321, 1996.

A. Sakamoto, M. Abe, and T. Masaka, Delineation of genomic deletion in cardiomyopathic hamster, FEBS Letters, vol.1, issue.1, pp.124-128, 1999.
DOI : 10.1016/S0014-5793(99)00267-7

F. Rivier, A. Robert, M. Royuela, G. Hugon, A. Bonet-kerrache et al., Utrophin and dystrophin-associated glycoproteins in normal and dystrophin deficient cardiac muscle, Journal of Muscle Research and Cell Motility, vol.20, issue.3, pp.305-314, 1999.
DOI : 10.1023/A:1005426920070

K. H. Holt and K. P. Campbell, Assembly of the Sarcoglycan Complex. INSIGHTS FOR MUSCULAR DYSTROPHY, Journal of Biological Chemistry, vol.273, issue.52, pp.34667-34670, 1998.
DOI : 10.1074/jbc.273.52.34667

E. M. Mcnally, D. Duggan, J. R. Gorospe, C. G. Bonnemann, M. Fanin et al., Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy, Human Molecular Genetics, vol.5, issue.11, pp.1841-1847, 1996.
DOI : 10.1093/hmg/5.11.1841

W. Shi, Z. Chen, J. Schottenfeld, R. C. Stahl, L. M. Kunkel et al., Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan, Muscle & Nerve, vol.276, issue.3, pp.29-409, 2004.
DOI : 10.1002/mus.10566

S. Manttari and M. Jarvilehto, Comparative analysis of mouse skeletal muscle fibre type composition and contractile responses to calcium channel blocker, BMC Physiol, vol.5, issue.4, 2005.

K. G. Beam, T. Tanabe, and S. Numa, Structure, Function, and Regulation of the Skeletal Muscle Dihydropyridine Receptor, Annals of the New York Academy of Sciences, vol.264, issue.1 Calcium Chann, pp.127-137, 1989.
DOI : 10.1016/0378-1119(82)90184-6

S. Manttari, Dihidropyridine receptors in skeletal muscle with comparative reference to muscle development and exercise in mouse and salmon, 2005.

Y. Iwata, Y. Katanosaka, Z. Shijun, Y. Kobayashi, H. Hanada et al., Protective effect of Ca 2+ handling drugs against abnormal Ca 2+ homeostasis and cell damage in myopathic skeletal muscle cells, Biochem. Pharmacol, pp.70-740, 2005.

. Maatsuzaki, Alterations in cardiac SR Ca(2+)-release channels during development of heart-failure in cardiomyopathic hamsters, Am. J. Physiol, vol.274, pp.1-7, 1998.